Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Squamous cell carcinoma of mouth
|
1 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
CANCER PROGRESSION AND TUMOR CELL MOTILITY
|
1 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.700 | 0 | |||||||
Node-positive breast cancer
|
3 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2006 | 2015 | ||||
Well Differentiated Pancreatic Endocrine Tumor
|
3 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Islet Cell Tumor
|
5 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Oropharynx (excludes nasopharynx)
|
5 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Sarcoma of soft tissue
|
6 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Progression of prostate cancer
|
7 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Diarrhoea predominant irritable bowel syndrome
|
8 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Pituitary-dependent Cushing's disease
|
8 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Febrile Neutropenia
|
14 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Neuroendocrine Tumors
|
20 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Squamous cell carcinoma of oropharynx
|
33 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Eclampsia
|
38 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1 | 2011 | 2011 | |||||
Sarcoma
|
42 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Tumor Progression
|
72 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.030 | 1.000 | 3 | 2004 | 2015 | ||||
Cholelithiasis
|
90 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Benign Prostatic Hyperplasia
|
91 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Carcinoma
|
103 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Head and Neck Carcinoma
|
118 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Body Fat Distribution
|
119 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Secondary malignant neoplasm of lymph node
|
188 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Liver Cirrhosis
|
189 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 |